Lista de obras - Suzanne J. Hodgkinson - Dominio Público Uruguay

A neuropsychological comparison of siblings with neurological versus hepatic symptoms of Wilson's Disease

artículo científico publicado en 2014

A new era in the treatment of multiple sclerosis

artículo científico publicado en 2015

Alloantigen specific T regulatory cells in transplant tolerance.

artículo científico publicado en 2009

Anti-neuronal antibodies associated with a first episode of mania

artículo científico publicado en 2014

C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy

artículo científico publicado en 2007

CD4(+), CD25(+) T cells as regulators of alloimmune responses

artículo científico publicado en 2001

CD4+CD25+ T cells alloactivated ex vivo by IL-2 or IL-4 become potent alloantigen-specific inhibitors of rejection with different phenotypes, suggesting separate pathways of activation by Th1 and Th2 responses

scientific article published on 30 September 2008

Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis

artículo científico publicado en 2015

Contribution of different relapse phenotypes to disability in multiple sclerosis.

artículo científico publicado en 2016

Cytokines affecting CD4(+) T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4(+)CD25(+) Treg.

artículo científico publicado en 2013

Decreasing presentations of seizures to emergency departments in a large Australian population

scientific article published on 22 September 2009

Defining secondary progressive multiple sclerosis

artículo científico publicado en 2016

Distinct regulatory CD4+T cell subsets; differences between naïve and antigen specific T regulatory cells ⬇️

artículo científico publicado el 11 de agosto de 2011

Donor IL-4-treatment induces alternatively activated liver macrophages and IDO-expressing NK cells and promotes rat liver allograft acceptance.

artículo científico publicado en 2009

Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.

artículo científico publicado en 1996

Heart allograft acceptance induced by anti-CD3 antibody in high-responder rats: effect on foxp3 and cytokine expression and graft infiltration

artículo científico publicado en 2008

Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis.

artículo científico publicado en 2016

Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis

artículo científico publicado en 2016

IL-13 prolongs allograft survival: association with inhibition of macrophage cytokine activation

artículo científico publicado en 2006

IL-5 promotes induction of antigen-specific CD4+CD25+ T regulatory cells that suppress autoimmunity

artículo científico publicado en 2012

Immune dysregulation and autoimmunity in bipolar disorder: Synthesis of the evidence and its clinical application.

artículo científico

Induction of antigen specific CD4(+)CD25(+)Foxp3(+)T regulatory cells from naïve natural thymic derived T regulatory cells

artículo científico publicado en 2015

Interleukin-12 (IL-12p70) Promotes Induction of Highly Potent Th1-Like CD4(+)CD25(+) T Regulatory Cells That Inhibit Allograft Rejection in Unmodified Recipients.

artículo científico publicado en 2014

Longitudinal assessment of anxiety, depression, and fatigue in people with multiple sclerosis.

artículo científico publicado en 2008

Membrane attack complex of complement is not essential for immune mediated demyelination in experimental autoimmune neuritis

artículo científico publicado en 2010

Mycophenolate mofetil treatment accelerates recovery from experimental allergic encephalomyelitis.

artículo científico publicado en 2001

Posttransplant interleukin-4 treatment converts rat liver allograft tolerance to rejection

artículo científico publicado en 2005

Prevalence of positive syphilis serology and meningovascular neurosyphilis in patients admitted with stroke and TIA from a culturally diverse population (2005-09).

artículo científico

Protective effects of transgenic human endothelial protein C receptor expression in murine models of transplantation.

artículo científico publicado en 2012

Relationship between stress and relapse in multiple sclerosis: Part I. Important features

artículo científico publicado en 2006

Relationship between stress and relapse in multiple sclerosis: Part II. Direct and indirect relationships.

artículo científico publicado en 2006

Repeated treatment with chimeric anti-CD4 antibody in multiple sclerosis

artículo científico publicado en 1994

Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis

artículo científico publicado en 2016

Should all patients with an initial diagnosis of multiple sclerosis be treated with beta interferon?

artículo científico publicado en 2001

Studies on naïve CD4+CD25+T cells inhibition of naïve CD4+CD25- T cells in mixed lymphocyte cultures

artículo científico publicado en 2007

Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis

artículo científico publicado en 2015

The Effect of Biofeedback as a Psychological Intervention in Multiple Sclerosis: A Randomized Controlled Study

artículo científico publicado en 2015

The cellular basis of cardiac allograft rejection. IX. Ratio of naïve CD4+CD25+ T cells/CD4+CD25- T cells determines rejection or tolerance

artículo científico publicado en 2006

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 1 historical and established therapies. MS Neurology Group of the Australian and New Zealand Association of Neurolo

artículo científico

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy. MS Neurology Group of the Australian and New Zealand Association o

artículo científico publicado en 2014

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 3 treatment practicalities and recommendations. MS Neurology Group of the Australian and New Zealand Association of

artículo científico

Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.

artículo científico publicado en 2017

Transfer of allograft specific tolerance requires CD4+CD25+T cells but not interleukin-4 or transforming growth factor-beta and cannot induce tolerance to linked antigens

artículo científico publicado en 2007

Transfer of experimental allergic neuritis by intra neural injection of sensitized lymphocytes

scientific article published on 01 May 1994

Transplant tolerance associated with a Th1 response and not broken by IL-4, IL-5, and TGF-beta blockade or Th1 cytokine administration

artículo científico publicado en 2007

Treatment of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with intravenous immunoglobulin in a patient with multiple sclerosis treated with fingolimod after discontinuation of natalizumab.

artículo científico publicado en 2014

Tumor necrosis factor alpha and interleukin-6 mRNA expression in neonatal Lewis rat Schwann cells and a neonatal rat Schwann cell line following interferon gamma stimulation.

artículo científico publicado en 1996

Lista de obras de Suzanne J. Hodgkinson

A neuropsychological comparison of siblings with neurological versus hepatic symptoms of Wilson's Disease

A new era in the treatment of multiple sclerosis

Alloantigen specific T regulatory cells in transplant tolerance.

Anti-neuronal antibodies associated with a first episode of mania

C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy

CD4(+), CD25(+) T cells as regulators of alloimmune responses

CD4+CD25+ T cells alloactivated ex vivo by IL-2 or IL-4 become potent alloantigen-specific inhibitors of rejection with different phenotypes, suggesting separate pathways of activation by Th1 and Th2 responses

Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis

Contribution of different relapse phenotypes to disability in multiple sclerosis.

Cytokines affecting CD4(+) T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4(+)CD25(+) Treg.

Decreasing presentations of seizures to emergency departments in a large Australian population

Defining secondary progressive multiple sclerosis

Distinct regulatory CD4+T cell subsets; differences between naïve and antigen specific T regulatory cells ⬇️

Donor IL-4-treatment induces alternatively activated liver macrophages and IDO-expressing NK cells and promotes rat liver allograft acceptance.

Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.

Heart allograft acceptance induced by anti-CD3 antibody in high-responder rats: effect on foxp3 and cytokine expression and graft infiltration

Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis.

Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis

IL-13 prolongs allograft survival: association with inhibition of macrophage cytokine activation

IL-5 promotes induction of antigen-specific CD4+CD25+ T regulatory cells that suppress autoimmunity

Immune dysregulation and autoimmunity in bipolar disorder: Synthesis of the evidence and its clinical application.

Induction of antigen specific CD4(+)CD25(+)Foxp3(+)T regulatory cells from naïve natural thymic derived T regulatory cells

Interleukin-12 (IL-12p70) Promotes Induction of Highly Potent Th1-Like CD4(+)CD25(+) T Regulatory Cells That Inhibit Allograft Rejection in Unmodified Recipients.

Longitudinal assessment of anxiety, depression, and fatigue in people with multiple sclerosis.

Membrane attack complex of complement is not essential for immune mediated demyelination in experimental autoimmune neuritis

Mycophenolate mofetil treatment accelerates recovery from experimental allergic encephalomyelitis.

Posttransplant interleukin-4 treatment converts rat liver allograft tolerance to rejection

Prevalence of positive syphilis serology and meningovascular neurosyphilis in patients admitted with stroke and TIA from a culturally diverse population (2005-09).

Protective effects of transgenic human endothelial protein C receptor expression in murine models of transplantation.

Relationship between stress and relapse in multiple sclerosis: Part I. Important features

Relationship between stress and relapse in multiple sclerosis: Part II. Direct and indirect relationships.

Repeated treatment with chimeric anti-CD4 antibody in multiple sclerosis

Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis

Should all patients with an initial diagnosis of multiple sclerosis be treated with beta interferon?

Studies on naïve CD4+CD25+T cells inhibition of naïve CD4+CD25- T cells in mixed lymphocyte cultures

Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis

The Effect of Biofeedback as a Psychological Intervention in Multiple Sclerosis: A Randomized Controlled Study

The cellular basis of cardiac allograft rejection. IX. Ratio of naïve CD4+CD25+ T cells/CD4+CD25- T cells determines rejection or tolerance

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 1 historical and established therapies. MS Neurology Group of the Australian and New Zealand Association of Neurolo

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy. MS Neurology Group of the Australian and New Zealand Association o

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 3 treatment practicalities and recommendations. MS Neurology Group of the Australian and New Zealand Association of

Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.

Transfer of allograft specific tolerance requires CD4+CD25+T cells but not interleukin-4 or transforming growth factor-beta and cannot induce tolerance to linked antigens

Transfer of experimental allergic neuritis by intra neural injection of sensitized lymphocytes

Transplant tolerance associated with a Th1 response and not broken by IL-4, IL-5, and TGF-beta blockade or Th1 cytokine administration

Treatment of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with intravenous immunoglobulin in a patient with multiple sclerosis treated with fingolimod after discontinuation of natalizumab.

Tumor necrosis factor alpha and interleukin-6 mRNA expression in neonatal Lewis rat Schwann cells and a neonatal rat Schwann cell line following interferon gamma stimulation.